Anne Willemsen

Anne Willemsen joined the Dutch National Healthcare Institute in 2016, and currently is Chair of the Joint Clinical Assessment (JCA) subgroup under the EU HTA Regulation’s Coordination Group, after having served the JCA Subgroup as co-chair for the past three years (2023-2026). She leads the subgroup through the preparatory phase of the JCA process and will guide it through the production of Joint Clinical Assessments started as of January 2025. Previously she held several roles within the European Network for HTA (EUnetHTA), including spearheading the Secretariat responsible for coordinating JCAs and joint work with the European Medicines Agency. Her work also focused on patient involvement and conflict of interest procedures. With a background in Health Sciences and a recently started PhD, she brings extensive experience in European HTA collaboration, focusing on predictability of the procedures, transparency and stakeholder engagement in JCA.